Pfizer, BioNTech Apply For COVID-19 Vaccine's Marketing Authorization In EU

Pharmaceutical giant Pfizer Inc. and German biotech firm BioNTech SE have submitted a formal Application for Conditional Marketing Authorization or CMA for their mRNA -based COVID-19 vaccine candidate, BNT162b2, to the European Medicines Agency or EMA. The companies hope that a CMA could potentially enable the use of BNT162b2 in Europe before the end of 2020.